Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-03 Sale | 2024-12-04 4:36 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 21,495 | $36.68 | $788,437 | 9,679 (Direct) | View |
| 2024-11-11 Sale | 2024-11-12 4:15 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 10,700 | $36.24 | $387,768 | 130,275 (Direct) | View |
| 2024-11-08 Sale | 2024-11-12 4:14 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 8,722 | $36.28 | $316,434 | 28,395 (Direct) | View |
| 2024-11-08 Sale | 2024-11-12 4:13 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 10,787 | $36.3 | $391,568 | 13,315 (Direct) | View |
| 2024-11-08 Sale | 2024-11-12 4:11 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 125,000 | $36.29 | $4,536,250 | 1,948,622 (Indirect Direct) | View |
| 2024-11-07 Sale | 2024-11-08 4:13 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 15,000 | $36.98 | $554,700 | 8,200 (Direct) | View |
| 2024-11-07 Sale | 2024-11-08 4:11 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 14,213 | $36.62 | $520,480 | 24,102 (Direct) | View |
| 2024-11-07 Sale | 2024-11-08 4:08 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 125,000 | $36.68 | $4,585,000 | 2,073,622 (Indirect Direct) | View |
| 2024-09-13 Sale | 2024-09-17 4:10 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 13,886 | $31.33 | $435,048 | 38,315 (Direct) | View |
| 2024-03-21 Sale | 2024-03-25 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 14,491 | $35.31 | $511,677 | 21,315 (Direct) | View |
| 2024-03-20 Sale | 2024-03-22 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 400 | $35.31 | $14,124 | 35,806 (Direct) | View |
| 2024-03-19 Sale | 2024-03-21 5:01 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 12,364 | $35.31 | $436,573 | 36,206 (Direct) | View |
| 2024-03-13 Sale | 2024-03-15 6:39 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 62,366 | $33.74 | $2,104,289 | 17,320 (Direct) | View |
| 2024-03-12 Sale | 2024-03-14 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,884 | $32.99 | $128,133 | 44,686 (Direct) | View |
| 2024-02-26 Sale | 2024-02-28 5:01 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 5,000 | $30.21 | $151,050 | 8,570 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-03 Exercise | 2024-12-04 4:36 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 8,750 | $23.99 | 9,679 (Direct) | View |
| 2024-12-03 Exercise | 2024-12-04 4:36 pm | N/A 2030-02-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 21,495 | $0 | 9,679 (Direct) | View |
| 2024-12-03 Exercise | 2024-12-04 4:36 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 12,745 | $25.3 | 9,679 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-12 4:15 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 20,000 | $9.13 | 130,275 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-12 4:15 pm | 2016-03-03 2025-03-03 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 20,000 | $0 | 130,275 (Direct) | View |
| 2024-11-08 Exercise | 2024-11-12 4:13 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 10,787 | $11.46 | 13,315 (Direct) | View |
| 2024-11-08 Exercise | 2024-11-12 4:13 pm | 2016-03-23 2025-03-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 10,787 | $0 | 13,315 (Direct) | View |
| 2024-11-08 Exercise | 2024-11-12 4:11 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 125,000 | $9.13 | 1,948,622 (Direct) | View |
| 2024-11-08 Exercise | 2024-11-12 4:11 pm | 2016-03-03 2025-03-03 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 125,000 | $0 | 1,948,622 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-08 4:13 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 15,000 | $9.13 | 8,200 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-08 4:13 pm | 2016-03-03 2025-03-03 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 15,000 | $0 | 8,200 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-08 4:11 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 14,213 | $11.46 | 24,102 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-08 4:11 pm | 2016-03-23 2025-03-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 14,213 | $0 | 24,102 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-08 4:08 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 125,000 | $9.13 | 2,073,622 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-08 4:08 pm | 2016-03-03 2025-03-03 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 125,000 | $0 | 2,073,622 (Direct) | View |
| 2024-09-13 Exercise | 2024-09-17 4:10 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 10,000 | $11.46 | 38,315 (Direct) | View |
| 2024-09-13 Exercise | 2024-09-17 4:10 pm | 2016-03-23 2025-03-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 10,000 | $0 | 38,315 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-03 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 10,045 | $34.9 | 1,948,622 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-03 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 21,000 | $0 | 1,948,622 (Direct) | View |
| 2024-08-27 Option Award | 2024-08-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 21,000 | $0 | 1,958,667 (Direct) | View |
| 2024-08-20 Exercise | 2024-08-20 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,250 | $0 | 9,679 (Direct) | View |
| 2024-08-20 Tax Withholding | 2024-08-20 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 572 | $29.57 | 9,679 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-14 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,250 | $0 | 10,251 (Direct) | View |
| 2024-03-21 Exercise | 2024-03-25 5:00 pm | N/A 2027-02-24 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 14,491 | $0 | 21,315 (Direct) | View |
| 2024-03-21 Exercise | 2024-03-25 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 14,491 | $25.3 | 21,315 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 5:00 pm | N/A 2027-02-24 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 400 | $0 | 35,806 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 400 | $25.3 | 35,806 (Direct) | View |
| 2024-03-19 Exercise | 2024-03-21 5:01 pm | N/A 2027-02-24 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 12,364 | $0 | 36,206 (Direct) | View |
| 2024-03-19 Exercise | 2024-03-21 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 12,364 | $25.3 | 36,206 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 6:39 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 36,116 | $12.98 | 17,320 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 6:39 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 26,250 | $23.99 | 17,320 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 6:39 pm | N/A 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 62,366 | $0 | 17,320 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-14 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,884 | $12.98 | 44,686 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-14 5:00 pm | N/A 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,884 | $0 | 44,686 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 460 | $27.94 | 7,779 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 990 | $0 | 7,779 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 16,788 | $27.94 | 1,937,667 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 35,000 | $0 | 1,937,667 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-28 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 5,000 | $9.13 | 8,570 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-28 5:01 pm | N/A 2025-03-03 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 5,000 | $0 | 8,570 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 3,886 | $0 | 120,975 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 3,886 | $0 | 120,975 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 3,886 | $0 | 17,201 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 3,886 | $0 | 17,201 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 3,886 | $0 | 17,201 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 3,886 | $0 | 17,201 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:03 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 3,886 | $0 | 37,117 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:03 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 3,886 | $0 | 37,117 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director | 3,886 | $0 | 87,943 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director | 3,886 | $0 | 87,943 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 1,875 | $0 | 12,874 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 937 | $29.06 | 12,874 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 1,875 | $0 | 12,874 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,250 | $0 | 12,320 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 638 | $29.06 | 12,320 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,250 | $0 | 12,320 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 2,500 | $0 | 14,690 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 1,314 | $29.06 | 14,690 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 2,500 | $0 | 14,690 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 1,250 | $0 | 8,391 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 567 | $29.06 | 8,391 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 1,250 | $0 | 8,391 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 1,250 | $0 | 90,683 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 485 | $29.06 | 90,683 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 1,250 | $0 | 90,683 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:03 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 13,621 | $0 | 26,936 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:02 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 13,621 | $0 | 26,936 (Direct) | View |
| 2024-02-22 Disposition | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 750 | $0 | 35,458 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 30,750 | $0 | 35,458 (Direct) | View |
| 2024-02-22 Tax Withholding | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 303 | $27.94 | 35,458 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:02 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 13,621 | $0 | 130,710 (Direct) | View |
| 2024-02-22 Disposition | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 750 | $0 | 34,458 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 25,750 | $0 | 34,458 (Direct) | View |
| 2024-02-22 Tax Withholding | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 372 | $27.94 | 34,458 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:01 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director | 13,621 | $0 | 97,678 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:01 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director | 13,621 | $0 | 13,621 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:01 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 13,621 | $0 | 46,852 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:01 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 357,000 | $0 | 2,276,455 (Direct) | View |